Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CD39 anticorps (Extracellular Loop)

Cet anticorps anti-CD39 Polyclonal Lapin (ABIN7043112) détecte spécifiquement CD39 dans WB, FACS et LCI. L’anticorps est réactif avec des échantillons de Humain.
N° du produit ABIN7043112
977,85 €
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 8 à 9 jours ouvrables

Aperçu rapide pour CD39 anticorps (Extracellular Loop) (ABIN7043112)

Antigène

Voir toutes CD39 (ENTPD1) Anticorps
CD39 (ENTPD1) (Ectonucleoside Triphosphate diphosphohydrolase 1 (ENTPD1))

Reactivité

  • 123
  • 38
  • 30
  • 4
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Humain

Hôte

  • 63
  • 58
  • 9
  • 8
  • 1
Lapin

Clonalité

  • 96
  • 42
  • 1
Polyclonal

Conjugué

  • 87
  • 8
  • 7
  • 6
  • 6
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CD39 est non-conjugé

Application

  • 47
  • 46
  • 38
  • 23
  • 14
  • 13
  • 12
  • 6
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Flow Cytometry (FACS), Live Cell Imaging (LCI)
  • Épitope

    • 8
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 398-411, Extracellular Loop

    Fonction

    A Rabbit Polyclonal Antibody to CD39

     Réactivité croisée

    Humain, Souris

    Homologie

    14 amino acid residues identical, rat - 11,Mouse - 12

    Attributs du produit

    Anti-CD39 (extracellular) Antibody (ABIN7043112, ABIN7044809 and ABIN7044810) is a highly specific antibody directed against an epitope of the human protein. The antibody can be used in western blot and indirect live cell flow cytometry applications. It has been designed to recognize ENTPD1 from rat, mouse, and human samples.

    Purification

    Affinity purified on immobilized antigen.

    Immunogène

    (C)KTSYAGVKEKYLSE, corresponding to amino acid residues 398-411 of human CD39

    Isotype

    IgG
  • Indications d'application

    WB: 1:200-1:400

    FC: 2.5 μg per reaction

    ICC: The optimal concentration should be determined by the user

    IHC: The optimal concentration should be determined by the user

    IP: The optimal concentration should be determined by the user

    Commentaires

    Negative Control: (ABIN7235254)

    Blocking Peptide: (ABIN7235254)

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    25 μL, 50 μL or 0.2 mL double distilled water (DDW), depending on the sample size.

    Concentration

    0.8 mg/mL

    Buffer

    PBS pH 7.4, 1 % BSA with 0.05 % sodium azide

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C
  • Antigène

    CD39 (ENTPD1) (Ectonucleoside Triphosphate diphosphohydrolase 1 (ENTPD1))

    Autre désignation

    ENTPD1

    Sujet

    Synonyms: Ectonucleoside triphosphate diphosphohydrolase 1, NTPDase 1, Ecto-ATP diphosphohydrolase 1, Ecto-ATPDase 1, Ecto-apyrase, Lymphoid cell activation antigen, ENTPD1

    Description: Ectonucleoside triphosphate diphosphohydrolase 1 (NTPDase1, ENTPD1, or CD39) is an enzyme that catalyzes the phosphohydrolysis of extracellular adenosine triphosphate (eATP) and diphosphate (eADP), that are released following inflammatory stress and cell injury, to adenosine monophosphate (AMP). AMP is then used by the ecto-5'-nucleotidase CD73 to synthesize adenosine1.Hydrolysis of adenosine triphosphate and adenosine diphosphate, performed by CD39, suppresses the immune system and inhibits T-cell and Natural killer (NK) cell responses. This inhibition has a role in promoting Chronic lymphocytic leukemia (CLL) and hence it is proposed that blockade or inhibition of CD39 may be a target for new immune therapy for CLL2. CD39 activity is also related to the occurrence of calcific aortic valve disease (CAVD)3, and to various other types of immune responses4. In addition, CD39 plays a dominant role in the purinergic regulation of inflammation1.The transcription of CD39 is constitutive in microvascular endothelium and certain immune cells. The modulated expression of NTPDase1 has been closely associated with inflammatory cytokines, oxidative stress and hypoxia in vitro and in vivo5.Localization of CD39 within lipid rafts suggests that this ecto-enzyme may be involved in cell-cell contact and signaling6.CD39 is a part of the ectonucleoside triphosphate dyphosphohydrolases (eNTDPase) protein family which shares a unique structural feature: instead of being anchored in the membrane by a single transmembrane domain or lipid link like other ectoenzymes, these proteins contain two transmembrane domains, one at each end of the protein. The active site lies in the large extracellular region. In addition, all family members share a set of short sequences termed apyrase conserved regions (ACRs)7.

    ID gène

    953

    NCBI Accession

    NM_001776

    UniProt

    P49961
Vous êtes ici:
Chat with us!